Log in

Relevant bibliographies by topics / Chronic systolic heart failure

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Chronic systolic heart failure'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Chronic systolic heart failure.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Chronic systolic heart failure"

1

Hőgye, Márta, and Tamás Forster. "Chronic heart failure with impaired left ventricular function (systolic heart failure)." Orvosi Hetilap 153, no. 51 (2012): 2021–29. http://dx.doi.org/10.1556/oh.2012.29502.

Full text

Abstract:

Chronic heart failure is a common public health problem. The disease has a poor prognosis with high mortality rate and the incidence increases continuously. Prognosis of chronic systolic heart failure can be improved by several different medications as well as by special cardiac interventions based on the newly-published European and American guidelines. In case of severe systolic dysfunction, hospitalization and mortality can be reduced using angiotensin converting enzyme inhibitors, angiotensin receptor blocking drugs, beta-receptor blocking agents and aldosterone antagonists, as evidenced i

APA, Harvard, Vancouver, ISO, and other styles

2

Chatterjee, Kanu, and J. Eduardo Rame. "Systolic heart failure: Chronic and acute syndromes." Critical Care Medicine 36, Suppl (2008): S44—S51. http://dx.doi.org/10.1097/01.ccm.0000296267.84202.b0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Mörike, K., and J. Sindermann. "Drug Treatment for Chronic Systolic Heart Failure." Thoracic and Cardiovascular Surgeon 58, S 02 (2010): S170—S172. http://dx.doi.org/10.1055/s-0029-1240711.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Geraci, Stephen A., Jessie M. Spencer, and Nancy D. Stubbs. "Office Management of Chronic Systolic Heart Failure." American Journal of Medicine 122, no. 4 (2009): 329–32. http://dx.doi.org/10.1016/j.amjmed.2008.12.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Maack, Christoph, and Michael Böhm. "Pharmacological Treatment of Patients with Chronic Systolic Heart Failure." European Cardiology Review 9, no. 1 (2014): 43. http://dx.doi.org/10.15420/ecr.2014.9.1.43.

Full text

Abstract:

Chronic heart failure is characterised by neuroendocrine activation as an attempt of the body to maintain pump function of the heart and blood pressure for the perfusion of peripheral tissues. While this neuroendocrine activation is beneficial in the short term, it induces maladaptive remodeling of the heart with continuous deterioration of left ventricular function. Accordingly, pharmacological treatment of patients with heart failure aims at protecting the heart from this neuroendocrine activation, which is represented in particular by the sympathetic nervous and the renin-angiotensin-aldost

APA, Harvard, Vancouver, ISO, and other styles

6

Xydonas, Sotirios, John Parissis, Louiza Lioni, et al. "Immunosenescence in patients with chronic systolic heart failure." Journal of Cardiovascular Medicine 17, no. 8 (2016): 624–30. http://dx.doi.org/10.2459/jcm.0000000000000372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Langford, Mary C. "Type 2 Diabetes and Chronic Systolic Heart Failure." Journal of Cardiovascular Nursing 19, Supplement (2004): S35—S44. http://dx.doi.org/10.1097/00005082-200411001-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

&NA;, &NA;. "Type 2 Diabetes and Chronic Systolic Heart Failure." Journal of Cardiovascular Nursing 19, Supplement (2004): S45—S46. http://dx.doi.org/10.1097/00005082-200411001-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bleske, Barry E. "Evolution and Pathophysiology of Chronic Systolic Heart Failure." Pharmacotherapy 20, no. 11 Part 2 (2000): 349S—358S. http://dx.doi.org/10.1592/phco.20.18.349s.34605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

El-Armouche, Ali, Noriyuki Ouchi, Komei Tanaka, et al. "Follistatin-Like 1 in Chronic Systolic Heart Failure." Circulation: Heart Failure 4, no. 5 (2011): 621–27. http://dx.doi.org/10.1161/circheartfailure.110.960625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Chronic systolic heart failure"

1

Siamkouris, Dimitrios [Verfasser], and Angelika [Akademischer Betreuer] Costard-Jäckle. "Iron deficiency in chronic heart failure with severely depressed systolic left ventricular function / Dimitrios Siamkouris. Betreuer: Angelika Costard-Jäckle." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2013. http://d-nb.info/1032313145/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Johansson, Peter. "Health‐related quality of life, depression, sleep and breathing disorders in the elderly : With focus on those with impaired systolic function/heart failure." Doctoral thesis, Linköpings universitet, Kardiologi, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-15784.

Full text

Abstract:

The overall aim of this thesis was to describe the prevalence of depressive symptoms, sleep disordered breathing (SDB) and sleep complaints, as well as to investigate the prognostic value of health-related quality of life (Hr-QoL) and depressive symptoms on mortality in an elderly community living population with a focus on those with impaired systolic function/heart failure (HF). Descriptive, prognostic and explorative study designs were used to examine if a single question about global perceived health (GPH) is associated with the domains of Hr-QoL as assessed by the SF-36 (I), as well as to

APA, Harvard, Vancouver, ISO, and other styles

3

Talwar, Suneel. "Molecular forms of brain natriuretic peptide and cardiotrophin-1 in the assessment of left ventricular systolic dysfunction after myocardial infarction and in subjects with chronic heart failure." Thesis, University of Leicester, 2000. http://hdl.handle.net/2381/29618.

Full text

Abstract:

Heart failure is common, has a poor prognosis and can be treated. The incidence is increasing, partly because of improved survival after myocardial infarction and partly because the population is aging and heart failure is a disease of the elderly. Despite advances in our understanding of the pathophysiology of heart failure, the diagnosis of heart failure remains enigmatic and requires the skills of the physician. Those skills have not yet been superseded by technology. The natriuretic peptide family of hormones have been used extensively to study a range of cardiovascular disorders. Plasma l

APA, Harvard, Vancouver, ISO, and other styles

4

Loh, Poay Huan. "Biomarkers of neurohormonal activation, on-going myocardial damage, haemostasis and inflammation in patients with stable chronic heart failure due to left ventricular systolic dysfunction and potential novel treatment." Thesis, University of Hull, 2014. http://hydra.hull.ac.uk/resources/hull:10518.

Full text

Abstract:

The prognosis of patients with chronic heart failure (CHF) due to left ventricular systolic dysfunction (LVSD) remains poor despite the progress in modern therapy. Btype natriuretic peptide (BNP) is a useful diagnostic and most consistent prognostic markers in CHF. However, treatment strategy guided by natriuretic peptides does not necessarily improve the outcome. In addition to myocardial remodelling, CHF is a systemic syndrome involving neurohormonal activation, inflammatory up-regulation, endothelial dysfunction and haemopoietic, haemostatic and haemorrheologic disturbance. In patients with

APA, Harvard, Vancouver, ISO, and other styles

5

Mathieu, Myrielle. "Comparison between therapeutic efficiency of bone marrow derived mononuclear and mesenchymal stem cells in chronic myocardial infarction." Doctoral thesis, Universite Libre de Bruxelles, 2009. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210138.

Full text

Abstract:

<p>Background: Stem cell therapy can facilitate cardiac repair after healed myocardial infarction but the optimal cell type remains uncertain. <p>Aims: To investigate the pathophysiology of heart failure in a canine model of healed myocardial infarction and to compare the efficacy and the safety of autologous bone marrow mononuclear cell (BMNC) transfer and mesenchymal stem cell (MSC) transfer in this model. It was a blind, randomized and placebo control study.<p>Methods: Eleven weeks after coronary ligation, 24 dogs received intramyocardial injections of BMNC, MSC or Placebo (n = 8 per groups

APA, Harvard, Vancouver, ISO, and other styles

6

Huiskes, Bonita Louise. "Advanced heart failure in older women with heart failure and preserved systolic function." Diss., Search in ProQuest Dissertations & Theses. UC Only, 2009. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3390049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Cowburn, Pete James. "Endothelin and chronic heart failure." Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.324790.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Khrebtiy, G. I. "Chronic heart failure (pathogenetic aspects)." Thesis, БДМУ, 2017. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/17094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Guha, Kaushik. "Cardiac Resynchronisation Therapy and its effects on systolic heart failure." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24931.

Full text

Abstract:

Cardiac Resynchronisation Therapy (CRT) is now an established therapeutic option for patients with symptomatic left ventricular systolic dysfunction, broad QRS duration (>120 milliseconds on surface electrocardiogram) and on optimal tolerated medical therapy. The numbers of implants are rising throughout the Westernised world. The United Kingdom has also had a rapid increase in CRT implantation. Despite the large randomised trials which prove clinical effectiveness, there is a realisation that a significant minority of patients who undergo CRT implantation do not derive the anticipated clinica

APA, Harvard, Vancouver, ISO, and other styles

10

Von, Lanzenauer Stephan Haehling. "Studies of immune function in chronic heart failure, inflammation in the progression of chronic heart failure." Thesis, Imperial College London, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516814.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Chronic systolic heart failure"

1

Viefhues, Herbert, Wolfgang Schoene, R. Rychlik, Asher Kimchi, Basil S. Lewis, and Marija Weiss, eds. Chronic Heart Failure. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-76433-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Böhm, Michael, and Erland Erdmann. Chronic Heart Failure. Edited by Erland Erdmann and Gerhard Riecker. Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-85913-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Böhm, M. Chronic heart failure. Springer, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bussmann, Wulf-Dirk. Acute and Chronic Heart Failure. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-61627-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Stewart, Simon, and Lynda Blue, eds. Improving Outcomes in Chronic Heart Failure. BMJ Publishing Group, 2004. http://dx.doi.org/10.1002/9780470750551.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

W, Davies Simon, ed. Clinician's manual on chronic heart failure. Science Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

National Institute for Clinical Excellence. Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. NICE, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

National Institute for Clinical Excellence. Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. NICE, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

A, Konstam Marvin, Dracup Kathleen, and United States. Agency for Health Care Policy and Research., eds. Heart failure: Management of patients with left-ventricular systolic dysfunction. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

United States. Agency for Health Care Policy and Research, ed. Heart failure: Management of patients with left-ventricular systolic dysfunction. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Chronic systolic heart failure"

1

Puri, Kriti, Kyle D. Hope, and Daniel J. Penny. "Chronic Left Ventricular Systolic Heart Failure." In Simulation in Cardiovascular Critical Care Medicine. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-63557-1_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Anand, Inder S., and Viorel G. Florea. "Structural Remodeling in the Development of Chronic Systolic Heart Failure: Implication for Treatment." In Congestive Heart Failure and Cardiac Transplantation. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-44577-9_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

E. Hogan, Shea, and Jennifer A. Cowger. "Systolic Heart Failure." In Inpatient Cardiovascular Medicine. John Wiley & Sons Inc, 2013. http://dx.doi.org/10.1002/9781118484784.ch12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Teeters, J. Chad, and Jeffrey D. Alexis. "Systolic Heart Failure." In Manual of Heart Failure Management. Springer London, 2009. http://dx.doi.org/10.1007/978-1-84882-185-9_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Leung, Alexander K. C., Cham Pion Kao, Andrew L. Wong, et al. "Systolic Heart Failure." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_8680.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rao, Vijay U., and John R. Teerlink. "Treating Systolic Heart Failure." In Management of Heart Failure. John Wiley & Sons, Ltd, 2010. http://dx.doi.org/10.1002/9780470669402.ch13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lewis, William, and Jim Nuovo. "Heart Failure." In Chronic Disease Management. Springer New York, 2007. http://dx.doi.org/10.1007/978-0-387-49369-5_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Carabello, Blase A. "Abnormalities in Cardiac Contraction: Systolic Dysfunction." In Congestive Heart Failure. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4613-8315-4_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Holley, Christopher, and Michael W. Rich. "Chronic Heart Failure." In Handbook of Clinical Nutrition and Aging. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-385-5_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ogah, Okechukwu Samuel, Anastase Dzudie, Dike Bevis Ojji, and Mahmoud Sani. "Chronic heart failure." In The Heart of Africa. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119097136.ch14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Chronic systolic heart failure"

1

Naresh, P., P. Namratha, T. Kavitha, Sathvik Chaganti, Sivananda Lahari Reddy Elicherla, and K. Gurnadha Gupta. "Utilizing Machine Learning for the Identification of Chronic Heart Failure (CHF) from Heart Pulsations." In 2024 4th International Conference on Ubiquitous Computing and Intelligent Information Systems (ICUIS). IEEE, 2024. https://doi.org/10.1109/icuis64676.2024.10866468.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

de Abreu, Raphael Martins, Beatrice Cairo, Vlasta Bari, et al. "Cardiorespiratory Coupling and Exercise Capacity in Patients with Chronic Heart Failure." In 2024 13th Conference of the European Study Group on Cardiovascular Oscillations (ESGCO). IEEE, 2024. http://dx.doi.org/10.1109/esgco63003.2024.10767063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sergi, Ilaria, Teodoro Montanaro, Roberto De Fazio, et al. "Innovative Approaches to Chronic Heart Failure Monitoring: A Critical Analysis of Wearable Devices." In 2024 9th International Conference on Smart and Sustainable Technologies (SpliTech). IEEE, 2024. http://dx.doi.org/10.23919/splitech61897.2024.10612481.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Viggiano, Davide. "Effects of Pulmonary Hypertension in Patients with Chronic Kidney Disease." In 7 th International Congress of Cardionephrology - KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.124v.

Full text

Abstract:

Pulmonary hypertension (PH) is a significant comorbidity in chronic kidney disease (CKD), with complex mechanisms linking the renal, cardiovascular, and pulmonary systems. Signs of pulmonary insufficiency and right heart failure should prompt transthoracic echocardiography with an estimate of pulmonary artery systolic pressure (PASP) from tricuspid regurgitation velocity.

APA, Harvard, Vancouver, ISO, and other styles

5

Brown, Oliver, Maria Sklirou, Joe Cuthbert, et al. "108 The relation between change in left ventricular systolic function and subsequent mortality in patients with chronic heart failure." In British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, 6–8 June 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bcs.108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sze, Shirley, Pierpaolo Pellicori, Syed Kamzi, Alexandru Anton, and Andrew Clark. "37 Effect of beta-andrenergic blockade on weight changes in chronic heart failure patients due to left ventricular systolic dysfunction." In British Cardiovascular Society Annual Conference ‘High Performing Teams’, 4–6 June 2018, Manchester, UK. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcs.37.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Fernandes Trevizan, Patricia, Renata Pletsch, Mayra C. Pereira, et al. "Effects of inspiratory muscle training and aerobic training on inspiratory muscle strength in chronic systolic heart failure patients: a pilot study." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Šarac, Ivana. "The basic principles of diet therapy in the treatment of patients with associated heart and kidney diseases." In 7th International Congress of Cardionephrology KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.231s.

Full text

Abstract:

The relationship between chronic kidney disease (CKD) and cardiovascular disease (CVD) is extensively documented in the literature. Patients with CKD exhibit an elevated cardiovascular risk, often presenting edema, imbalance in electrolytes, proteins, lipoproteins, hormones (including vitamin D, parathormone, renin-angiotensin-aldosterone system), enzymes, growth factors, cytokines, endothelial dysfunction, inflammation, oxidative stress, insulin resistance, and anemia, leading to cardiovascular remodeling. This results in hypertension, arteriosclerosis, arterial and cardiac valve calcificatio

APA, Harvard, Vancouver, ISO, and other styles

9

Fonseca, Abner Lourenço da. "Constrictive Pericarditis." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-079.

Full text

Abstract:

Abstract The pericardium is a fibrous membrane that surrounds the heart and is composed of two components: visceral pericardium and parietal pericardium. Under physiological conditions, it performs important functions, such as lubrication, which minimizes friction between the organ and adjacent structures, limits intrathoracic cardiac motion, aids in filling the cardiac chambers, and participates in the balancing between the right and left ventricles during diastole and systole interactions. Constrictive Pericarditis occurs when the pericardium is thickened, fibrotic and often calcified, signi

APA, Harvard, Vancouver, ISO, and other styles

10

Magh, A., J. Prudenti, C. Castaneda, C. Rhee, and O. A. Abe. "Leukostasis-Related Decompensated Systolic Right Heart Failure." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1961.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Chronic systolic heart failure"

1

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text

Abstract:

Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Ke

APA, Harvard, Vancouver, ISO, and other styles

2

Thomas, Kevin, Andrzej Kosinski, Sana Al-Khatib, Samuel Sears, and Nancy Lapointe. Helping Black Patients Decide on a Treatment for Chronic Heart Failure -- The VIVID Study. Patient-Centered Outcomes Research Institute® (PCORI), 2022. http://dx.doi.org/10.25302/04.2022.ad.150329746.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Whitehead, William, Curtis Rozzelle, Jay Riva-Cambrin, et al. Helping Black Patients Decide on a Treatment for Chronic Heart Failure -- The VIVID Study. Patient-Centered Outcomes Research Institute® (PCORI), 2022. http://dx.doi.org/10.25302/05.2022.cer.140313857.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Qian, Tang, Liu Lin, Lin Liu, and CHen Min. Effects of vitamin D supplementation on Patients with chronic heart failure: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.4.0032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Holdsworth, Clark, Steven Copp, Daniel Hirai, Scott Ferguson, Timothy Musch, and David Poole. Effects of dietary fish oil on exercising muscle blood flow in chronic heart failure rats. Peeref, 2022. http://dx.doi.org/10.54985/peeref.2206p4902539.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Brown, Yolanda, Twonia Goyer, and Maragaret Harvey. Heart Failure 30-Day Readmission Frequency, Rates, and HF Classification. University of Tennessee Health Science Center, 2020. http://dx.doi.org/10.21007/con.dnp.2020.0002.

Full text

Abstract:

30 Day Hospital Readmission Rates, Frequencies, and Heart Failure Classification for Patients with Heart Failure Background Congestive heart failure (CHF) is the leading cause of mortality, morbidity, and disability worldwide among patients. Both the incidence and the prevalence of heart failure are age dependent and are relatively common in individuals 40 years of age and older. CHF is one of the leading causes of inpatient hospitalization readmission in the United States, with readmission rates remaining above the 20% goal within 30 days. The Center for Medicare and Medicaid Services imposes

APA, Harvard, Vancouver, ISO, and other styles

7

Gao, Peng, Xian Wu, Fu-hua Zhang, Zhi-li Qiao, and Li-jie Yang. Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.5.0029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zhang, Bin, Ming Zhang, Cao-Jie Lu, Li-Zhi Liu, Chen Jiang, and Ming-Jin Zhu. Effect of Znic Supplementation on Patients with Chronic Heart Failure: A systematic Review and Meta Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.1.0100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Liu, Wenlong, Xu Zhang, Kai Liu, and Zhongjing Kang. Lung ultrasound-guided treatment in chronic heart failure: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0117.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Yang, zeqi, qiuhong Guo, yangyang Han, fan Gao, jiaye Tian, and ran Bai. Effects of traditional chinese medicine intervention on the gut microbiota in patients with chronic heart failure. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.6.0006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!